MedPath

Angeliq

Brand Name: Angeliq

Generic Name: Drospirenone + Estradiol

Active
Registration Number

DR-XY30778

Dosage Form

Tablet

Issuance Date

April 1, 2025

Expiry Date

May 19, 2031

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength2 mg/ 1 mg
PackagingBlister Pack x 28's

Classification

C
Classification
Prescription Drug (RX)
P
Pharmacologic
Hormonal Replacement Therapy
A
Application
Renewal
Philippine FDA Classification

Active Ingredients (2)

Complete list of active ingredients in this pharmaceutical product.

DrospirenoneActive
Monograph: Drospirenone
EstradiolActive
Monograph: Estradiol

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform